Peripheral Vascular Devices | Market Insights | Asia Pacific (Supplemental) | 2022
While the COVID-19 pandemic will have a negative impact on the Asia Pacific peripheral vascular device market in the short term, the market will grow modestly through 2030, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy devices. However, lack of reimbursement, cost constraints, and the impact of COVID-19 pandemic will limit market growth to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in the Asia Pacific region across an 11-year period.
